{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:27:34Z","timestamp":1788852454264,"version":"build-2803163510"},"reference-count":94,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750266"],"award-info":[{"award-number":["2024M750266"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Postdoctoral Fellowship Program of CPSF","award":["GZC20240164"],"award-info":[{"award-number":["GZC20240164"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20240484736"],"award-info":[{"award-number":["20240484736"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing University of Chinese Medicine affiliated Dongzhimen Hospital's Youth Backbone Talent Program","award":["DZMG-QNGG007"],"award-info":[{"award-number":["DZMG-QNGG007"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Uric acid (UA) is considered as a potential risk factor for coronary heart disease (CHD) and other cardiovascular diseases (CVDs). However, the association between hyperuricemia and the risk of CHD and other cardiovascular outcomes has not been fully clarified. This systematic review and dose-response meta-analysis was conducted to comprehensively the association between hyperuricemia and the risk of CHD or other cardiovascular outcomes in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched Medline, Cochrane Library, Embase, and two clinical trial registration databases from inception to June 30, 2025, without restrictions on language or publication status. Only cohort and case-control studies enrolling participants without CHD, other CVDs, or gout at baseline were included. The primary outcome was the association between hyperuricemia and the risk of CHD, and secondary outcomes were the association between hyperuricemia and the risk of fatal and nonfatal CVDs, included CHD death, CVD, CVD death, and myocardial infarction (MI). Risk of bias was assessed using the Risk Of Bias In Non-randomized Studies-of Exposure (ROBINS-E) tool. All statistical analyses were performed using R 4.4.2. We conducted meta-analyses, heterogeneity assessments, publication bias tests, trim-and-fill analyses, subgroup and sensitivity analyses, meta-regressions, and dose-response meta-analyses. The GRADE recommendation was used to evaluate the quality of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 42 articles representing 39 individual studies and 1,082,880 participants were included. Among these, 2 articles were assess as \u201cvery high risk of bias\u201d, eight as \u201chigh risk of bias\u201d, and two as \u201csome concerns\u201d. Hyperuricemia was significantly associated with an increased risk of CHD [HR 1.21 (95%CI 1.14\u20131.28), p\u2009&lt;\u20090.001, I2\u2009=\u200934.34%], CHD death [1.20 (1.05\u20131.36), p\u2009=\u20090.005, I2\u2009=\u200941.28%], CVD death [1.75 (1.12\u20132.74), p\u2009=\u20090.014, I2\u2009=\u200949.48%], and MI [1.23 (1.03\u20131.47), p\u2009=\u20090.025, I2\u2009=\u200956.96%]. No significant association was observed for overall CVD risk [1.09 (0.94\u20131.27), p\u2009=\u20090.245, I2\u2009=\u20090%]. For each unit increase in serum UA, the risk of CHD, CHD death, CVD, CVD death, and MI increased by 16%, 13%, 12%, 11%, and 7%, respectively. No factors with a significant impact on the results were identified through subgroup analyses or meta-regression. Sex may have a potential influence, but the results were not robust. Further dose-response meta-analysis revealed a linear relationship between higher serum UA and CVD risk, and a U-shaped association between serum UA and CVD mortality in men. The quality of evidence was rated as low for CHD and very low for the other cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic review and dose-response meta-analysis provides low- to very-low-quality evidence suggesting that hyperuricemia may be associated with an increased risk of CHD and other fatal or nonfatal CVDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was registered in PROSPERO CRD42024538553.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337091","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T18:27:55Z","timestamp":1763490475000},"page":"e0337091","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of hyperuricemia with coronary heart disease and other cardiovascular outcomes: A systematic review and dose-response meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-2382","authenticated-orcid":true,"given":"Diyang","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9117-6957","authenticated-orcid":true,"given":"Yiming","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"8","key":"pone.0337091.ref001","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association","volume":"149","author":"SS Martin","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"pone.0337091.ref002","doi-asserted-by":"crossref","first-page":"16812","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"AK Malakar","year":"2019","journal-title":"J Cell Physiol"},{"issue":"20","key":"pone.0337091.ref003","article-title":"Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association","volume":"151","author":"SS Khan","year":"2025","journal-title":"Circulation"},{"key":"pone.0337091.ref004","article-title":"Crystal clear - part I: The role of uric acid in cardiorenal disease","author":"C Borghi","year":"2025","journal-title":"Eur J Intern Med"},{"key":"pone.0337091.ref005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","article-title":"Uric acid in metabolic syndrome: From an innocent bystander to a central player","volume":"29","author":"M Kanbay","year":"2016","journal-title":"Eur J Intern Med"},{"key":"pone.0337091.ref006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.acc.2023.05.003","article-title":"Uric acid en route to gout","volume":"116","author":"W-Z Zhang","year":"2023","journal-title":"Adv Clin Chem"},{"issue":"1","key":"pone.0337091.ref007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2016:4:2","article-title":"Uric Acid and Cardiovascular Disease: An Update","volume":"11","author":"ML Muiesan","year":"2016","journal-title":"Eur Cardiol"},{"issue":"3","key":"pone.0337091.ref008","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2017-0954","article-title":"Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease","volume":"56","author":"F Braga","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"pone.0337091.ref009","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2017-0487","article-title":"Hyperuricemia does not seem to be an independent risk factor for coronary heart disease","volume":"56","author":"A Battaggia","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"pone.0337091.ref010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"F Braga","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"pone.0337091.ref011","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","article-title":"Association of serum uric acid and cardiovascular disease in healthy adults","volume":"111","author":"S Kivity","year":"2013","journal-title":"Am J Cardiol"},{"issue":"12","key":"pone.0337091.ref012","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10067-013-2339-7","article-title":"Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease","volume":"32","author":"A Onat","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"4","key":"pone.0337091.ref013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1539\/sangyoeisei.B12007","article-title":"Assessment of the risk of ischemic heart disease and its relevant factors among Japanese police officers","volume":"55","author":"M Shiozaki","year":"2013","journal-title":"Sangyo Eiseigaku Zasshi"},{"issue":"6","key":"pone.0337091.ref014","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","article-title":"Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)","volume":"266","author":"I Holme","year":"2009","journal-title":"J Intern Med"},{"issue":"3","key":"pone.0337091.ref015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9343(80)90111-4","article-title":"High uric acid as an indicator of cardiovascular disease. Independence from obesity","volume":"68","author":"WJ Fessel","year":"1980","journal-title":"Am J Med"},{"key":"pone.0337091.ref016","doi-asserted-by":"crossref","first-page":"19520","DOI":"10.1038\/srep19520","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"M Li","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"pone.0337091.ref017","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinte.1995.00430070036004","article-title":"Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program","volume":"155","author":"RJ Goldberg","year":"1995","journal-title":"Arch Intern Med"},{"issue":"1","key":"pone.0337091.ref018","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12933-023-02022-z","article-title":"Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"O De Filippo","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0337091.ref019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2020.03.083","article-title":"Associations between changes in serum uric acid and the risk of myocardial infarction","volume":"314","author":"X Tian","year":"2020","journal-title":"Int J Cardiol"},{"issue":"12","key":"pone.0337091.ref020","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/j.numecd.2021.08.043","article-title":"High-level uric acid in asymptomatic hyperuricemia could be an isolated risk factor of cardio-cerebrovascular diseases: A prospective cohort study","volume":"31","author":"Z Cheng","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"pone.0337091.ref021","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/biomedicines11082212","article-title":"Elevated Uric Acid Levels with Early Chronic Kidney Disease as an Indicator of New-Onset Ischemic Heart Disease: A Cohort of Koreans without Diabetes","volume":"11","author":"S-B Lee","year":"2023","journal-title":"Biomedicines"},{"issue":"10","key":"pone.0337091.ref022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029633","article-title":"Association of Normal Serum Uric Acid Level and Cardiovascular Disease in People Without Risk Factors for Cardiac Diseases in China","volume":"12","author":"X Tian","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"pone.0337091.ref023","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3899\/jrheum.210139","article-title":"Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death","volume":"48","author":"LD Colantonio","year":"2021","journal-title":"J Rheumatol"},{"key":"pone.0337091.ref024","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000836576.02695.89","article-title":"CARDIOVASCULAR DISEASE RISK PREDICTION IN EASTERN EUROPE ACCORDING TO 5-YEARS PROSPECTIVE STUDY","volume":"40","author":"V Podpalov","year":"2022","journal-title":"Journal of Hypertension"},{"issue":"8","key":"pone.0337091.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308719","article-title":"Association of hyperuricemia with coronary heart disease: Protocol for an updated systematic review and dose-response meta-analysis","volume":"19","author":"J Chen","year":"2024","journal-title":"PLoS One"},{"key":"pone.0337091.ref026","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","author":"JPT Higgins","year":"2024"},{"issue":"1","key":"pone.0337091.ref027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"MJ Page","year":"2021","journal-title":"Syst Rev"},{"issue":"15","key":"pone.0337091.ref028","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"DF Stroup","year":"2000","journal-title":"JAMA"},{"key":"pone.0337091.ref029","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"JPT Higgins","year":"2024","journal-title":"Environ Int"},{"issue":"2","key":"pone.0337091.ref030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"S Duval","year":"2000","journal-title":"Biometrics"},{"key":"pone.0337091.ref031","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v072.c01","article-title":"Multivariate Dose-Response Meta-Analysis: ThedosresmetaRPackage","volume":"72","author":"A Crippa","year":"2016","journal-title":"J Stat Soft"},{"issue":"4","key":"pone.0337091.ref032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"pone.0337091.ref033","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12872-025-04866-7","article-title":"Serum uric acid and coronary artery disease risk: a 10-year prospective cohort study in healthy adults","volume":"25","author":"M Sarebanhassanabadi","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0337091.ref034","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0001022404.68474.3c","article-title":"The association of serum uric acid levels with cardiovascular morbidity and mortality","volume":"42","author":"M Boyarinova","year":"2024","journal-title":"Journal of Hypertension"},{"issue":"2","key":"pone.0337091.ref035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/hrt.78.2.147","article-title":"Serum urate and the risk of major coronary heart disease events","volume":"78","author":"SG Wannamethee","year":"1997","journal-title":"Heart"},{"issue":"4","key":"pone.0337091.ref036","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00001648-199907000-00009","article-title":"Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases","volume":"10","author":"AD Liese","year":"1999","journal-title":"Epidemiology"},{"issue":"3","key":"pone.0337091.ref037","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.hjr.0000130222.50258.22","article-title":"Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men","volume":"11","author":"SH Jee","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"2","key":"pone.0337091.ref038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2007.094425","article-title":"Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men","volume":"54","author":"A Strasak","year":"2008","journal-title":"Clin Chem"},{"issue":"2","key":"pone.0337091.ref039","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2007.11.094","article-title":"Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study","volume":"125","author":"AM Strasak","year":"2008","journal-title":"Int J Cardiol"},{"issue":"9","key":"pone.0337091.ref040","article-title":"Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"10","author":"H Wang","year":"2015","journal-title":"PLoS One"},{"issue":"46","key":"pone.0337091.ref041","doi-asserted-by":"crossref","first-page":"80688","DOI":"10.18632\/oncotarget.21079","article-title":"Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities","volume":"8","author":"J Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"pone.0337091.ref042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.HYP.0000200033.14574.14","article-title":"Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension","volume":"47","author":"Y Iwashima","year":"2006","journal-title":"Hypertension"},{"issue":"8","key":"pone.0337091.ref043","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/1440-1681.12928","article-title":"Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study","volume":"45","author":"I Andrikou","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"pone.0337091.ref044","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12933-023-02006-z","article-title":"Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study","volume":"22","author":"M Perticone","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"pone.0337091.ref045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1291\/hypres.30.823","article-title":"Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki","volume":"30","author":"T Baba","year":"2007","journal-title":"Hypertens Res"},{"issue":"18","key":"pone.0337091.ref046","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"J Fang","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"pone.0337091.ref047","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(99)00037-X","article-title":"Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study","volume":"10","author":"JT Moriarity","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"2","key":"pone.0337091.ref048","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24164","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","volume":"61","author":"J-H Chen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"pone.0337091.ref049","doi-asserted-by":"crossref","first-page":"110919","DOI":"10.1016\/j.diabres.2023.110919","article-title":"Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity","volume":"205","author":"D Wakabayashi","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"pone.0337091.ref050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"BF Culleton","year":"1999","journal-title":"Ann Intern Med"},{"issue":"6","key":"pone.0337091.ref051","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"MJ Bos","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"pone.0337091.ref052","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.hjr.0000192745.26973.00","article-title":"Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes","volume":"13","author":"Y Gerber","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"6","key":"pone.0337091.ref053","doi-asserted-by":"crossref","first-page":"692","DOI":"10.5551\/jat.31591","article-title":"Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study","volume":"23","author":"W Zhang","year":"2016","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"pone.0337091.ref054","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jech.2004.025510","article-title":"Residence in mountainous compared with lowland areas in relation to total and coronary mortality. A study in rural Greece","volume":"59","author":"N Baibas","year":"2005","journal-title":"J Epidemiol Community Health"},{"issue":"11","key":"pone.0337091.ref055","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/hr.2012.99","article-title":"Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients","volume":"35","author":"T Kawai","year":"2012","journal-title":"Hypertens Res"},{"issue":"3","key":"pone.0337091.ref056","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijcard.2013.12.029","article-title":"Serum uric acid and eGFR_CKDEPI differently predict long-term cardiovascular events and all causes of deaths in a residential cohort","volume":"171","author":"PE Puddu","year":"2014","journal-title":"Int J Cardiol"},{"issue":"10","key":"pone.0337091.ref057","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2020.07.054","article-title":"Contemporary risk factors for cardiovascular outcomes among men and women - insights from the cartagene study","volume":"36","author":"C Boutet","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"key":"pone.0337091.ref058","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2261-13-115","article-title":"Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Troms\u00f8 Study","volume":"13","author":"HM Storhaug","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0337091.ref059","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2016.09.035","article-title":"Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort","volume":"224","author":"X Lai","year":"2016","journal-title":"Int J Cardiol"},{"key":"pone.0337091.ref060","first-page":"1512","author":"A Mayo-Juanatey","year":"2025","journal-title":"HYPERURICEMIA AS CARDIOVASCULAR RISK FACTOR: A STUDY IN PATIENTS WITH RHEUMATIC DISEASES"},{"issue":"1","key":"pone.0337091.ref061","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2005.01.018","article-title":"Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study","volume":"183","author":"K-L Chien","year":"2005","journal-title":"Atherosclerosis"},{"issue":"3","key":"pone.0337091.ref062","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2011.06.055","article-title":"Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort","volume":"154","author":"S-Y Chuang","year":"2012","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0337091.ref063","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"L Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"pone.0337091.ref064","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment","volume":"23","author":"M-E Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0337091.ref065","doi-asserted-by":"crossref","first-page":"5817348","DOI":"10.1155\/2020\/5817348","article-title":"Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury","volume":"2020","author":"H-Y Su","year":"2020","journal-title":"Biomed Res Int"},{"issue":"6","key":"pone.0337091.ref066","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","article-title":"Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction","volume":"28","author":"M-A Yu","year":"2010","journal-title":"J Hypertens"},{"issue":"6","key":"pone.0337091.ref067","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3892\/br.2024.1859","article-title":"Effects of uric acid on oxidative stress in vascular smooth muscle cells","volume":"21","author":"S Dogru","year":"2024","journal-title":"Biomed Rep"},{"issue":"9","key":"pone.0337091.ref068","first-page":"1493","article-title":"The Association of Serum Uric Acid Levels and Various Uric Acid-Related Ratios with Insulin Resistance and Obesity: A Preliminary Study in Adolescents","volume":"10","author":"O Dikker","year":"2023","journal-title":"Children (Basel)"},{"key":"pone.0337091.ref069","doi-asserted-by":"crossref","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","article-title":"Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective","volume":"11","author":"W Yu","year":"2020","journal-title":"Front Pharmacol"},{"key":"pone.0337091.ref070","doi-asserted-by":"crossref","first-page":"131779","DOI":"10.1016\/j.ijcard.2024.131779","article-title":"Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis","volume":"399","author":"L Zheng","year":"2024","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0337091.ref071","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/hr.2011.169","article-title":"Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension","volume":"35","author":"H Ito","year":"2012","journal-title":"Hypertens Res"},{"issue":"1","key":"pone.0337091.ref072","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"F Rahimi-Sakak","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"pone.0337091.ref073","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/s41598-023-30902-7","article-title":"Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease","volume":"13","author":"M Prezelin-Reydit","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0337091.ref074","doi-asserted-by":"crossref","first-page":"633767","DOI":"10.3389\/fendo.2021.633767","article-title":"Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19","volume":"12","author":"B Chen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"pone.0337091.ref075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/biom14070753","article-title":"The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic Strategies","volume":"14","author":"Y Zheng","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"pone.0337091.ref076","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"YY Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"pone.0337091.ref077","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"J Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"issue":"11","key":"pone.0337091.ref078","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"DK Arnett","year":"2019","journal-title":"Circulation"},{"key":"pone.0337091.ref079","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000572844.50613.9a","article-title":"Prognostic cut-off values of serum uric acid associated with fatal and non fatal incident myocardial infarction independently of arterial hypertension in a large cohort","volume":"37","author":"E Casiglia","year":"2019","journal-title":"Journal of Hypertension"},{"issue":"10","key":"pone.0337091.ref080","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.numecd.2023.07.012","article-title":"High-normal serum uric acid predicts macrovascular events in patients with type 2 diabetes mellitus without hyperuricemia based on a 10-year cohort","volume":"33","author":"C Ma","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"pone.0337091.ref081","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/HJH.0000000000002287","article-title":"Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study","volume":"38","author":"E Casiglia","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"pone.0337091.ref082","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12872-023-03523-1","article-title":"Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis","volume":"23","author":"J Rong","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0337091.ref083","doi-asserted-by":"crossref","first-page":"785327","DOI":"10.3389\/fmed.2021.785327","article-title":"Serum Uric Acid and Risk of Chronic Heart Failure: A Systematic Review and Meta-Analysis","volume":"8","author":"L Miao","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"pone.0337091.ref084","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11239-021-02453-z","article-title":"Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis","volume":"52","author":"Y Yang","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"pone.0337091.ref085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/JMDH.S340596","article-title":"The Potential of Prognostic Biomarkers of Uric Acid Levels in Coronary Heart Disease Among Aged Population: A Scoping Systematic Review of the Latest Cohort Evidence","volume":"15","author":"S Maulana","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"pone.0337091.ref086","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00393-024-01600-0","article-title":"Effect of urate-lowering therapy on all-cause and CVD-specific mortality in gout and hyperuricemia: a meta-analysis","volume":"83","author":"YH Lee","year":"2024","journal-title":"Z Rheumatol"},{"key":"pone.0337091.ref087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2024.2430304","article-title":"Cardiovascular outcomes of urate-lowering therapies in patients with gout or hyperuricemia: a network meta-analysis","author":"Y Yan","year":"2024","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"pone.0337091.ref088","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11886-024-02138-y","article-title":"Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis","volume":"26","author":"Y Jamil","year":"2024","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"pone.0337091.ref089","article-title":"U-Shaped Association of Serum Uric Acid With All-Cause and Cause-Specific Mortality in US Adults: A Cohort Study","volume":"105","author":"L Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0337091.ref090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s40001-022-00888-5","article-title":"Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis","volume":"27","author":"Y-W Zou","year":"2022","journal-title":"Eur J Med Res"},{"issue":"4","key":"pone.0337091.ref091","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.semarthrit.2021.04.011","article-title":"Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis","volume":"51","author":"C-N Son","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0337091.ref092","volume-title":"GRADE handbook for grading quality of evidence and strength of recommendations","author":"H Sch\u00fcnemann","year":"2013"},{"issue":"6","key":"pone.0337091.ref093","first-page":"531","article-title":"Relation between uricemia and total, cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population","volume":"49","author":"AC Aboa Eboule","year":"2001","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"4","key":"pone.0337091.ref094","first-page":"311","article-title":"Multivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational male cohort","volume":"47","author":"A Menotti","year":"1992","journal-title":"Acta Cardiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T18:28:08Z","timestamp":1763490488000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337091"}},"subtitle":[],"editor":[{"given":"Andres Mauricio","family":"Acevedo-Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":94,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337091","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}